Anson Funds Management’s Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 PHIOW Stock Holding History

Anson Funds Management’s Portfolio PHIOW Stock Details PHIOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-86,299	Closed	-$232K	–	353
2020 Q4	$232K	Buy	+86,299	New	+$13.1K	0.05%	149
2019 Q4	–	Sell	-217,023	Closed	-$60	–	94
2019 Q3	$60	Hold	217,023	–	–	0.04%	32
2019 Q2	$82	Hold	217,023	–	–	0.04%	36
2019 Q1	$98K	Hold	217,023	–	–	0.07%	28
2018 Q4	$72K	Buy	+217,023	New	+$8.66K	0.04%	48

Other funds holding PHIOW

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Anson Funds Management's PHIOW Position: Q1 2021 in Review

Anson Funds Management sold out of Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) in Q1 2021, closing a stake of 86,299 shares — an estimated $232K sold.

Anson Funds Management first reported a position in PHIOW in Q4 2018 and held it in 5 quarters. The position peaked at $232K in Q4 2020. 2 funds tracked by Wall St. Rank hold PHIOW as of Q1 2021.

Anson Funds Management reported no remaining Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 position as of Q1 2021 after selling out during the quarter.
Anson Funds Management sold 86,299 Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 shares in Q1 2021, an estimated $232K.
Anson Funds Management first reported a position in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 in Q4 2018 and held it in 5 quarters.
Anson Funds Management's Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 position peaked at $232K in Q4 2020.
2 funds tracked by Wall St. Rank held Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 as of Q1 2021.

Based on Anson Funds Management's 13F filing for Q1 2021, filed 14 May 2021.